These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11554621)

  • 1. Antibodies in the treatment of lymphoma.
    Harvey ML; Illidge T; Johnson P
    Clin Oncol (R Coll Radiol); 2001; 13(4):251-61. PubMed ID: 11554621
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.
    Coiffier B
    Haematologica; 1999 Jun; 84 Suppl EHA-4():14-8. PubMed ID: 10907457
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215
    [No Abstract]   [Full Text] [Related]  

  • 4. Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.
    Scheinberg DA
    Curr Opin Immunol; 1991 Oct; 3(5):679-84. PubMed ID: 1661602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of patients with malignant lymphomas with monoclonal antibodies.
    Tesch H; Engert A; Manzke O; Diehl V; Bohlen H
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S50-3. PubMed ID: 10933189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of monoclonal antibody therapy for malignant lymphoma].
    Ogura M
    Nihon Rinsho; 2002 Mar; 60(3):505-16. PubMed ID: 11904966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies as carriers of toxins.
    Uhr JW; Fulton RJ; Till MA; May RD; Vitetta ES
    Prog Clin Biol Res; 1989; 288():403-12. PubMed ID: 2785694
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies.
    Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific monoclonal antibodies for the targeting of type I ribosome-inactivating proteins against hematological malignancies.
    Ferrini S; Sforzini S; Canevari S
    Methods Mol Biol; 2001; 166():177-92. PubMed ID: 11217367
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma.
    Schmitz N
    Ann Oncol; 2008 Jul; 19 Suppl 5():v63-7. PubMed ID: 18611903
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation and use of anti-idiotypic antibodies armed with holotoxins or hemitoxins in treatment of B-cell neoplasms.
    Bridges S; Longo DL; Youle RJ
    Methods Enzymol; 1989; 178():356-68. PubMed ID: 2601625
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody therapy of cancer.
    Jurcic JG; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1994; 15():152-75. PubMed ID: 7779584
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologicals for cancer treatment: monoclonal antibodies.
    Levy R
    Hosp Pract (Off Ed); 1985 Nov; 20(11):67-74, 77, 80-4 passim. PubMed ID: 3932392
    [No Abstract]   [Full Text] [Related]  

  • 14. [Monoclonal antibody treatment of malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Internist (Berl); 2004 Dec; 45(12):1370-7. PubMed ID: 15517123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies in the treatment of malignant lymphoma].
    Niu Y; Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):435-41. PubMed ID: 16900652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinoma therapy with monoclonal antibodies.
    Canevari S; Miotti S; Bottero F; Valota O; Colnaghi MI
    Hybridoma; 1993 Oct; 12(5):501-7. PubMed ID: 8300122
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bispecific antibodies in hematology and oncology].
    Repp R; Valerius T; Bargou R
    Internist (Berl); 2001 Jun; 42(6):854-9. PubMed ID: 11449632
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal antibodies in adult acute lymphoblastic leukemia.
    Kantarjian H
    Hematology; 2012 Apr; 17 Suppl 1():S52-4. PubMed ID: 22507779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody-based therapies of leukemia and lymphoma.
    Grossbard ML; Press OW; Appelbaum FR; Bernstein ID; Nadler LM
    Blood; 1992 Aug; 80(4):863-78. PubMed ID: 1498329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.